These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 19939637)

  • 1. Pulmonary drug delivery systems for antimicrobial agents: facts and myths.
    Falagas ME; Michalopoulos A; Metaxas EI
    Int J Antimicrob Agents; 2010 Feb; 35(2):101-6. PubMed ID: 19939637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Local administration of polymyxins into the respiratory tract for the prevention and treatment of pulmonary infections in patients without cystic fibrosis.
    Falagas ME; Kasiakou SK
    Infection; 2007 Feb; 35(1):3-10. PubMed ID: 17297582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delivery of antibiotics to the respiratory tract: an update.
    Traini D; Young PM
    Expert Opin Drug Deliv; 2009 Sep; 6(9):897-905. PubMed ID: 19637984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhaled antimicrobial therapy: from cystic fibrosis to the flu.
    O'Riordan TG
    Respir Care; 2000 Jul; 45(7):836-45. PubMed ID: 10926381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dry powder inhalation versus wet nebulisation delivery of antibiotics in cystic fibrosis patients.
    Westerman EM; Heijerman HG; Frijlink HW
    Expert Opin Drug Deliv; 2007 Mar; 4(2):91-4. PubMed ID: 17335406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhaled antibiotics for gram-negative respiratory infections.
    Hudson R; Olson Blair B
    Future Med Chem; 2011 Oct; 3(13):1663-77. PubMed ID: 21942255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in prevalence and treatment of Pseudomonas aeruginosa in cystic fibrosis centres in Denmark, Norway and Sweden.
    Knudsen PK; Olesen HV; Høiby N; Johannesson M; Karpati F; Laerum BN; Meyer P; Pressler T; Lindblad A;
    J Cyst Fibros; 2009 Mar; 8(2):135-42. PubMed ID: 19157995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Doripenem monohydrate, a broad-spectrum carbapenem antibiotic.
    Matthews SJ; Lancaster JW
    Clin Ther; 2009 Jan; 31(1):42-63. PubMed ID: 19243706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antibiotic treatment of cystic fibrosis].
    de Montalembert M; Berche P; Lenoir G
    Ann Pediatr (Paris); 1991 Oct; 38(8):523-8. PubMed ID: 1746849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single versus combined antibiotic therapy for gram-negative infections.
    Klibanov OM; Raasch RH; Rublein JC
    Ann Pharmacother; 2004 Feb; 38(2):332-7. PubMed ID: 14742774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aerosolized antibiotics in critically ill ventilated patients.
    Palmer LB
    Curr Opin Crit Care; 2009 Oct; 15(5):413-8. PubMed ID: 19657273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antibiotic inhalation in cystic fibrosis. A review of the literature].
    Steinkamp G
    Monatsschr Kinderheilkd; 1991 Feb; 139(2):73-80. PubMed ID: 1903843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biofilms and antibiotic therapy: is there a role for combating bacterial resistance by the use of novel drug delivery systems?
    Smith AW
    Adv Drug Deliv Rev; 2005 Jul; 57(10):1539-50. PubMed ID: 15950314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of hospital and home intravenous antibiotic therapy in adults with cystic fibrosis.
    Esmond G; Butler M; McCormack AM
    J Clin Nurs; 2006 Jan; 15(1):52-60. PubMed ID: 16390524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aminoglycosides are useful for severe respiratory tract infections.
    Craig WA; Andes D
    Semin Respir Infect; 1997 Dec; 12(4):271-7. PubMed ID: 9436954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of an alternative cefepime dosing strategy in pulmonary and bloodstream infections caused by Enterobacter spp, Citrobacter freundii, and Pseudomonas aeruginosa: a single-center, open-label, prospective, observational study.
    Deal EN; Micek ST; Reichley RM; Ritchie DJ
    Clin Ther; 2009 Feb; 31(2):299-310. PubMed ID: 19302902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhaled antimicrobial therapy - barriers to effective treatment.
    Weers J
    Adv Drug Deliv Rev; 2015 May; 85():24-43. PubMed ID: 25193067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination therapy with polymyxin B for the treatment of multidrug-resistant Gram-negative respiratory tract infections.
    Sobieszczyk ME; Furuya EY; Hay CM; Pancholi P; Della-Latta P; Hammer SM; Kubin CJ
    J Antimicrob Chemother; 2004 Aug; 54(2):566-9. PubMed ID: 15269195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Inhaled antibiotic therapy in other respiratory diseases].
    Baranda F; Gómez A; Gómez B
    Arch Bronconeumol; 2011 Jun; 47 Suppl 6():24-9. PubMed ID: 21703476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.